William J. Regan, SVP & CCO at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), bought 20,000 shares at $0.53 ($11K) on 2017-06-29, disclosed to the SEC on 2017-07-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |